Liposome encapsulated daunorubicin doubles anthracycline toxicity in cell lines showing a non-PGP related multidrug resistance.
Michieli
M
M
Damiani
D
D
Ermacora
A
A
Masolini
P
P
Michelutti
A
A
Baccarani
M
M
D018943:Anthracyclines / Q000008:administration & dosage / Q000633:toxicity; D003630:Daunorubicin / Q000008:administration & dosage* / Q000378:metabolism / Q000633:toxicity*; D004339:Drug Compounding / Q000379:methods*; D018432:Drug Resistance, Multiple; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage* / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000187:drug effects
D018943:Anthracyclines; D008081:Liposomes; D003630:Daunorubicin